Evidence map›Paper›PMID 39453024›Full record

ArticleFuture oncology (London, England)2024

Colorectal cancer research priorities in Uganda: perspectives from local key experts and stakeholders.

Nicholas Matovu, Noleb Mugume Mugisha, Alfred Jatho, Charlene M McShane

Abstract read
In one paragraph

Article in Future oncology (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nicholas MatovuUganda Cancer Institute, Kampala, Uganda.ORCID 0000-0003-4756-288X
Noleb Mugume MugishaUganda Cancer Institute, Kampala, Uganda.ORCID 0009-0000-4170-6884
Alfred JathoUganda Cancer Institute, Kampala, Uganda.ORCID 0000-0001-5733-2573
Charlene M McShaneCentre for Public Health, Queen's University Belfast, Belfast, UK.ORCID 0000-0001-8609-0788

Funding

Department for Economy Northern Ireland International Science Partnership Fund Official Development Assistance Institutional
6 · The paper itself

Abstract

The incidence of colorectal cancer (CRC) is increasing in Uganda but there is limited local research to guide policy and programming for CRC prevention and control. A stakeholder engagement workshop took place in Kampala on 19 March 2024 to identify challenges and opportunities for CRC prevention and control in Uganda. A total of 30 stakeholders with expertise in CRC primary and secondary prevention, diagnosis, treatment, palliative care as well as cancer survivors participated in the workshop. Key challenges for primary prevention included low knowledge/awareness of CRC among the general population and health workers, and rising prevalence of CRC related risk factors. Limited CRC screening, diagnostic facilities and specialists were identified as barriers to diagnosis. Treatment related challenges included limited accessibility to surgical services and drugs, late-stage presentation leading to poor treatment response, treatment abandonment and drug related toxicity. Lack of universal health coverage policies, limited community-based cancer awareness programs, and lack of national cancer registries were cited as policy and economics challenges. Opportunities to address these challenges were discussed. Our findings highlight areas for further research and prioritization to address Uganda's growing CRC burden and may be applicable to other low-resource settings.

Indexed as

Colorectal NeoplasmsEarly Detection of CancerBiomedical ResearchHealth Knowledge, Attitudes, PracticeHealth Services AccessibilityHumansIncidenceResearchRisk FactorsStakeholder ParticipationUgandacancer controlcolorectal cancerlow-and-middle income countriesstakeholders’ engagement workshopUganda

Identifiers

PMID39453024
PMCPMC11633408

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.